15th Apr 2024


US biotech giant Illumina to challenge EU merger veto

US biotech giant Illumina said on Tuesday the company will challenge the European Commission's prohibition of its $8bn acquisition of Grail — a firm that develops blood-based early cancer detection tests. "It is vital to preserve competition between early cancer detection test-developers at this critical stage of development," EU commissioner for competition Margrethe Vestager said, going against last week's ruling by the US federal trade commission.

Read and decide

Join EUobserver today

Get the EU news that really matters

Instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

UK-EU deal on Gibraltar only 'weeks away'

EU and UK negotiators said that a new post-Brexit settlement for Gibraltar was just weeks away from completion following four-way talks in Brussels on Friday (12 April).


Calling time on Amazon's monopolism and exploitation

As Amazon's founder Jeff Bezos just reclaimed the title of the richest person on Earth, its workers cannot even take a bathroom break under the pressure of meeting inhumane performance targets.

Resist backlash on deforestation law, green groups tell EU

European environmental groups have urged the EU Commission to stand firm on implementing the bloc's landmark anti-deforestation legislation — despite a backlash from governments in South America, Africa and some EU ministers.

Join EUobserver

EU news that matters

Join us